enVVeno Medical Corp — Investor Relations & Filings

enVVeno Medical Corp. is a late clinical-stage medical device company that develops bioprosthetic, tissue-based solutions to treat deep venous disease. The company's primary focus is on Chronic Venous Insufficiency (CVI), a condition resulting from damaged valves in the leg veins that causes insufficient blood return to the heart. Its portfolio of investigational products includes the VenoValve®, a surgical replacement venous valve, and the enVVe®, a next-generation, non-surgical, transcatheter-based replacement venous valve. Both product candidates are designed for the treatment of CVI in the deep veins and are currently in clinical development.